Pathway-based signature analysis of RNA-seq data to reveal new targetable avenues for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).

TitlePathway-based signature analysis of RNA-seq data to reveal new targetable avenues for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).
Publication TypeMiscellaneous
Year of Publication2014
AuthorsBivol, A, Baertsch, R, Sokolov, A, Paull, E, Newton, Y, Goldstein, TC, Foye, A, Pourmand, N, Youngren, J, Parulkar, R, ,